Cholesterol and Sphingomyelin Drive Ligand-independent T-cell Antigen Receptor Nanoclustering-Reference-Cited by-同舟云学术

Cholesterol and Sphingomyelin Drive Ligand-independent T-cell Antigen Receptor Nanoclustering

Published:2012-12 Issue:51 Volume:287 Page:42664-42674
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Molnár Eszter,Swamy Mahima,Holzer Martin,Beck-García Katharina,Worch Remigiusz,Thiele Christoph,Guigas Gernot,Boye Kristian,Luescher Immanuel F.,Schwille Petra,Schubert Rolf,Schamel Wolfgang W.A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference51 articles.

1. Ligand recognition by αβ T cell receptors;Davis;Annu. Rev. Immunol.,1998

2. An evolutionary and structural perspective on T cell antigen receptor function;Malissen;Immunol. Rev.,2003

3. The organizing principle in the formation of the T cell receptor-CD3 complex;Call;Cell,2002

4. Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response;Schamel;J. Exp. Med.,2005

5. A native antibody-based mobility-shift technique (NAMOS-assay) to determine the stoichiometry of multiprotein complexes;Swamy;J. Immunol. Methods,2007

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key links in the physiological regulation of the immune system and disease induction: T cell receptor -CD3 complex;Biochemical Pharmacology;2024-09

2. Fatostatin promotes anti-tumor immunity by reducing SREBP2 mediated cholesterol metabolism in tumor-infiltrating T lymphocytes;European Journal of Pharmacology;2024-05

3. Transient hydroxycholesterol treatment restrains TCR signaling to promote long-term immunity;Cell Chemical Biology;2024-05

4. Modulating Cholesterol Metabolism via ACAT1 Knockdown Enhances Anti-B-Cell Lymphoma Activities of CD19-Specific Chimeric Antigen Receptor T Cells by Improving the Cell Activation and Proliferation;Cells;2024-03-21

5. T cell receptor signaling and cell immunotherapy;National Science Open;2024-03-15